Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Fishman

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Addiction Biology|November 29, 2023
Fentanyl-induced respiratory depression in rodents is inhibited by bioabsorbable, subcutaneous naltrexone implants at 3.5 monthsJeffrey D Benner, Steven M Cohen, Joseph A Hollenbaugh, et al.
Paediatric Drugs|August 6, 2013
Pharmacologically assisted treatment of opioid-dependent youthAnna Pecoraro, Marc Fishman, Michelle Ma, et al.
Journal of Substance Abuse Treatment|December 10, 2020
Youth OUD treatment during and after COVID: Increasing family involvement across the services continuumAaron Hogue, Sara J Becker, Marc Fishman, et al.
The Journal of Clinical Psychiatry|April 22, 2022
Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection NaltrexonePeter J Na, Jennifer Scodes, Marc Fishman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
CorrespondenceMarc Fishman, William Shimp, James Krook, et al.
Journal of Substance Abuse Treatment|May 21, 2021
Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the Youth Opioid Recovery Support (YORS) interventionKevin Wenzel, Victoria Selby, Jared Wildberger, et al.
Journal of Addiction Medicine|December 12, 2018
Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical TrialMarc Fishman, Carlos Tirado, Danesh Alam, et al.
Journal of Addiction Medicine|May 11, 2026
Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use DisorderKevin R Wenzel, Jennifer Carrano, Amy Bormel, et al.
Journal of Addiction Medicine|May 11, 2021
Therapy Dose Mediates the Relationship Between Buprenorphine/Naloxone and Opioid Treatment Outcomes in Youth Receiving Medication for Opioid Use Disorder TreatmentChristopher J Hammond, Annabel Kady, Grace Park, et al.
Substance Use & Misuse|May 5, 2017
Trait Mindfulness and Progression to Injection Use in Youth With Opioid AddictionJ Deanna Wilson, Hoa Vo, Pamela Matson, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Addiction Biology|November 29, 2023
Fentanyl-induced respiratory depression in rodents is inhibited by bioabsorbable, subcutaneous naltrexone implants at 3.5 monthsJeffrey D Benner, Steven M Cohen, Joseph A Hollenbaugh, et al.
Paediatric Drugs|August 6, 2013
Pharmacologically assisted treatment of opioid-dependent youthAnna Pecoraro, Marc Fishman, Michelle Ma, et al.
Journal of Substance Abuse Treatment|December 10, 2020
Youth OUD treatment during and after COVID: Increasing family involvement across the services continuumAaron Hogue, Sara J Becker, Marc Fishman, et al.
The Journal of Clinical Psychiatry|April 22, 2022
Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection NaltrexonePeter J Na, Jennifer Scodes, Marc Fishman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
CorrespondenceMarc Fishman, William Shimp, James Krook, et al.
Journal of Substance Abuse Treatment|May 21, 2021
Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the Youth Opioid Recovery Support (YORS) interventionKevin Wenzel, Victoria Selby, Jared Wildberger, et al.
Journal of Addiction Medicine|December 12, 2018
Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical TrialMarc Fishman, Carlos Tirado, Danesh Alam, et al.
Journal of Addiction Medicine|May 11, 2026
Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use DisorderKevin R Wenzel, Jennifer Carrano, Amy Bormel, et al.
Journal of Addiction Medicine|May 11, 2021
Therapy Dose Mediates the Relationship Between Buprenorphine/Naloxone and Opioid Treatment Outcomes in Youth Receiving Medication for Opioid Use Disorder TreatmentChristopher J Hammond, Annabel Kady, Grace Park, et al.
Substance Use & Misuse|May 5, 2017
Trait Mindfulness and Progression to Injection Use in Youth With Opioid AddictionJ Deanna Wilson, Hoa Vo, Pamela Matson, et al.
Pageof 8